- Coordinator
- Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana, Spain
- Runs
- 1 September 2024 to 31 August 2029
- Status
- Running
- EU funding
- €12.4m
- Total cost
- €22.4m
- Partners
- 39 organisations in 17 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101172872
What the project is doing
In the project's own words, from its summary on CORDIS.
SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in healthcare applications. The project will improve the methodological and technical aspects of SD Generation (SDG) by developing new techniques and advancing established ones for different data modalities, including genomics and imaging, to improve the generation of realistic multimodal and longitudinal data.
This project will provide the research community with approaches for transparent benchmarking of alternative SDG methods for specific applications, identify and establish evaluation metrics and methodologies, and contribute to the standardisation of an evaluation assessment framework for SD. Robust evidence of SD applicability in a set of use cases across a broad spectrum of medical conditions will be crucial to demonstrate the potential of SD to accelerate data-driven solutions of equivalent quality to those derived from real patient data.
Furthermore, legal and regulatory implications of SD use will be analysed with the aim of delivering an assurance framework to guide secure SD utilization in healthcare. These significant breakthroughs will be implemented through the open SYNTHIA federated platform, facilitating responsible SD use by the health research community. The platform will facilitate users´ long-term access to extensively validated, reusable synthetic datasets, as well as to SDG workflows and SD assessment frameworks.
The federated infrastructure will rely on extended open-source frameworks for interoperability with other data-sharing infrastructures in the context of the European Health Data Space. A multidisciplinary collaboration of SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and communication experts will provide a 360º vision on how to advance healthcare applications through SD use.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana | Valencia | Spain | Coordinator |
| Universitat Wien | Wien | Austria | Participant |
| European Alliance for Personalised Medicine ASBL | Bruxelles / Brussel | Belgium | Participant |
| Janssen Pharmaceutica NV | Beerse | Belgium | Participant |
| The European Institute for Innovation Through Health Data | Gentbrugge | Belgium | Participant |
| Centre Hospitalier Universitaire Vaudois | Lausanne | Switzerland | Associatedpartner |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Ge Healthcare GmbH | Dusseldorf | Germany | Third party |
| Patvocates GmbH | Riemerling | Germany | Participant |
| Pfizer Pharma GmbH | Berlin | Germany | Associatedpartner |
| Novo Nordisk A/s | Bagsvaerd | Denmark | Participant |
| Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | Thermi Thessaloniki | Greece | Participant |
| Barcelona Supercomputing Center Centro Nacional De Supercomputacion | Barcelona | Spain | Participant |
| Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca | Barcelona | Spain | Participant |
| Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio) | Barcelona | Spain | Participant |
| General Electric Healthcare Espana SA | Madrid | Spain | Third party |
| Matical Innovation SL | Madrid | Spain | Participant |
| Universidad Politecnica De Madrid | Madrid | Spain | Participant |
| Hus-Yhtyma | Helsinki | Finland | Participant |
| Ge Medical Systems Scs | Buc | France | Participant |
| Ge Healthcare Magyarorszag Kft | Budapest | Hungary | Third party |
| Wipro GE Healthcare Private Ltd. | Kadugodi | India | Associatedpartner |
| Alma Mater Studiorum - Universita Di Bologna | Bologna | Italy | Participant |
| Azienda Unita' Sanitaria Locale Di Bologna | Bologna | Italy | Third party |
| Humanitas Mirasole SpA | Rozzano (Mi) | Italy | Participant |
| Irccs Azienda Ospedaliero- Universitaria Di Bologna | Bologna | Italy | Third party |
| Train SRL | Rozzano | Italy | Participant |
| Information Technology for Translational Medicine (ittm) SA | Esch-Uelzecht | Luxembourg | Participant |
| Academisch Ziekenhuis Leiden | Leiden | Netherlands | Participant |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Participant |
| Dnv AS | Hovik | Norway | Participant |
| Ge Healthcare Limited | Chalfont St Giles | United Kingdom | Associatedpartner |
| National Institute for Health and Care Excellence | Manchester | United Kingdom | Associatedpartner |
| Bristol-Myers Squibb Company Corp | New York | United States | Participant |
| Gates Ventures Llc | Kirkland | United States | Participant |
| GE Healthcare IITS USA Corp. | Chicago | United States | Associatedpartner |
| Pfizer Inc | New York City | United States | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI